Search results
AstraZeneca (AZN) Drugs Get CHMP Recommendation for Breast Cancer
Zacks via Yahoo Finance· 2 years agoThe EMA's Committee for Medicinal Products for Human Use recommends granting marketing approval to...
Merck cancer drug deal caps pharma investment influx into ‘ADC’ field
BioPharma Dive via Yahoo Finance· 6 months agoWith the alliance, Merck joins Pfizer, AstraZeneca and Gilead in staking major bets on the potential...
Roche (RHHBY) Breast Cancer Drug Meets Primary Goal in Phase III
Zacks via Yahoo Finance· 5 months agoRoche's (RHHBY) phase III study evaluating inavolisib in combination with advanced hormone...
AbbVie joins ADC dealmaking with $10B ImmunoGen buyout
BioPharma Dive via Yahoo Finance· 5 months agoAbbVie is expanding its investment in targeted cancer medicines, announcing Thursday a $10.1 billion...
Roche sceptical about investing more in 'guided-missile' ADC cancer drugs
Reuters via Yahoo News· 2 years agoMANNHEIM (Reuters) -Roche remains sceptical about investing more in antibody-drug conjugates (ADCs),...
ImmunoGen (IMGN) Ovarian Cancer Drug BLA Gets Priority Review
Zacks via Yahoo Finance· 2 years agoImmunoGen (IMGN) gets priority review from the FDA for the BLA seeking approval for its lead...
Seagen's breast cancer therapy succeeds in late-stage study
Reuters via Yahoo News· 8 months agoPfizer in March agreed to acquire Seagen and its targeted therapies in a $43 billion deal to help...
Seagen's (SGEN) Breast Cancer Study on Tuksya Combo Meets Goal
Zacks via Yahoo Finance· 8 months agoSeagen Inc. SGEN announced positive top-line results from its late-stage HER2CLIMB-02 study,...
New data sets stage for broader use of AstraZeneca breast cancer drug
Reuters via Yahoo News· 2 years agoAstraZeneca and Daiichi Sankyo's Enhertu extended survival by more than six months in patients with...
Roche (RHHBY) 1H Revenues, Earnings Down on Lower COVID-19 Test Sales
Zacks via Yahoo Finance· 9 months agoRoche Holding AG’s RHHBY performance in the first half was average, as COVID-19 product related...
